For pregnant women who are adjusting to their changing body image, appropriate management of acne is a key component of maintaining self-esteem and overall well-being.
The Food and Drug Administration has accepted for review the New Drug Application for a once-daily medication for the treatment of moderate to severe acne vulgaris in patients ≥9 years of age.
The researchers found that in both male and female patients, serum homocysteine levels were significantly higher compared to the healthy control group.
The opportunity exists to develop resiliency training programs and to explore their role in mitigating stress levels and depressive symptoms among patients with HS.
An international group of expert dermatologists with an interest in acne research and education have developed a consensus statement on the effective management of acne.
Dermatology Advisor Articles
- Specific Oral Bacteria May Reduce Risk for Squamous Cell Carcinoma
- Ostomy-Related Costs Reduced With Ceramide-Infused Skin Barrier
- Pediatric Psoriasis Associated With Increased Risk for Comorbidity Development
- Improved Neck, Décolletage Lines With Ultrasound, Diluted Calcium Hydroxylapatite
- New Nutrition Science Course Available for Physicians